XP-0863

Xeris Pharmaceuticals granted fast track designation by FDA for novel concentrated diazepam formulation for injection
Pharmaceutical Business Review
Wed, 10/21/20 - 10:34 am
Xeris Pharmaceuticals
acute repetitive seizures
XP-0863
FDA
diazepam
fast track